EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Capecitabine Dosage as an Independent Prognostic Factor for the Development of Hand-Foot Syndrome: A Competing Risk Analysis

Chaichana Chantharakhit iD, Jayanton Patumanond iD, Phichayut Phinyo iD, Chatree Chai-Adisaksopha

Drug, Healthcare and Patient Safety · 2026-02 · Volume 18 · 1-11

DOI: 10.2147/dhps.s567407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug, Healthcare and Patient Safety, 2026-02. Verfasst von Chaichana Chantharakhit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Buddhasothorn Hospital, Chachoengsao, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

capecitabine dosagecompeting risk analysishand-foot syndromeprognostic factor

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Buddhasothorn Hospital, Chachoengsao, Thailand.
  • Department of Biomedical Informatics and Clinical Epidemiology (BioCE), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Clinical Epidemiology and Clinical Statistics Unit, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand.
  • Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Chaichana Chantharakhit, Jayanton Patumanond, Phichayut Phinyo

Zitieren

APA

Chantharakhit, C., Patumanond, J., Phinyo, P., & Chai-Adisaksopha, C. (2026). Capecitabine Dosage as an Independent Prognostic Factor for the Development of Hand-Foot Syndrome: A Competing Risk Analysis. Drug, Healthcare and Patient Safety, Volume 18, 1-11. https://doi.org/10.2147/dhps.s567407

Vancouver

Chantharakhit C, Patumanond J, Phinyo P, Chai-Adisaksopha C. Capecitabine Dosage as an Independent Prognostic Factor for the Development of Hand-Foot Syndrome: A Competing Risk Analysis. Drug, Healthcare and Patient Safety. 2026;Volume 18:1-11. doi:10.2147/dhps.s567407

BibTeX
@article{Chantharakhit2026,
  author = {Chantharakhit, Chaichana and Patumanond, Jayanton and Phinyo, Phichayut and Chai-Adisaksopha, Chatree},
  title = {Capecitabine Dosage as an Independent Prognostic Factor for the Development of Hand-Foot Syndrome: A Competing Risk Analysis},
  journal = {Drug, Healthcare and Patient Safety},
  year = {2026},
  volume = {Volume 18},
  pages = {1--11},
  doi = {10.2147/dhps.s567407}
}
Kostenlos starten →